You will notice below that Houston and East Texas are not “getting better”—TEXAS numbers continue to rise. ICU’s are filling up in our area. Stay well.

Elysian Fields ISD to close elementary campus due to COVID-19

”…The announcement Tuesday said the school will close beginning Wednesday, Jan. 12 and not re-open for classes through next Tuesday, Jan. 18. Classes will resume Wednesday, Jan. 19…”

From THE ATLANTIC  this morning:(with some editing by J. Harris)

Three Reasons to Avoid Getting COVID Right Now:

Omicron is everywhere, and people are tired. Nearly two years into this pandemic, the seemingly more transmissible and milder coronavirus variant is tempting some to throw in the towel on avoiding infection…Should you just accept that you’re going to get sick this winter? No,…Though you will [might] probably get COVID eventually, there are a few practical reasons to delay [or prevent?] an infection—and potentially passing it on to others—as long as possible.

1. You can help reduce the burden on hospitals.

”…health-care workers are already burning out and quitting in droves. This latest surge could break our hospital systems. And broken hospitals affect not just COVID patients, but anyone seeking care.

2. Better treatments to help the most vulnerable are on the way.

“Pfizer’s very effective pill has just been authorized by the FDA, but supplies are short…“Only one monoclonal antibody, sotrovimab, currently works against Omicron, and supplies are also short.” The longer you’re able to stave off infection, the more time the system has to make these treatments available.

3. Getting it now doesn’t guarantee that you won’t get it again.

It’s not as simple as “getting it over with.” “No combinations of vaccines or viruses can confer invulnerability to future tussles with SARS-CoV-2,… “Whether acquired from an injection or an infection, immunity will always work in degrees, not absolutes.”


NOVAVAX Novavax expects its SARS-CoV-2 vaccine to receive regulatory approval in multiple countries, including the US, over the next several months, the company’s CEO, Stanley Erck, said on January 10. As expected, Novavax completed its data submission on its protein-based vaccine to the US FDA on December 31, a prerequisite for emergency use authorization (EUA) application. The company expects to file a request for an FDA EUA at the end of this month, and it has recently applied for authorization in other nations, including Japan, the United Arab Emirates, Singapore, New Zealand, Australia, South Africa, and the UK. Shipments of the vaccine have begun to the European Union, which authorized the vaccine last month. The WHO has issued emergency use listings for 2 versions of the vaccine (NVX-CoV2373): Nuvaxovid, which will be manufactured in Europe and is authorized for use by the European Medicines Agency; and Covovax, which will be manufactured by the Serum Institute of India and is authorized for use by the Drugs Controller General of India. Some experts feel the vaccine’s 6-month stability under simple refrigeration storage will make it particularly useful in low-income countries.



(J. Harris: Short, readable, and very important)

”…The national flu, pneumonia and/or COVID-19 mortality rate is 19.9 percent, which sits above the epidemic threshold of 6.9 percent. Among the 3,252 deaths reported for the week, 2,519 had COVID-19 listed as an underlying or contributing cause of death on the death certificate.”

Where people go wrong with ‘incidental’ COVID-19 hospitalizations

Mayo, Kaiser among companies investing $110M into ‘hospital-at-home’ venture


A commander walks into a bar and orders everyone around..   

 Never buy flowers from a monk. Only you can prevent florist friars.


GIVE US YOUR FEEDBACK.  CLICK ON “COMMENT” TO TELL US WHAT YOU THINK or use one of the alternative methods for providing feedback.

Click here to submit feedback.  Let us know what you think.

click here to CLOSE THIS PAGE


Click here to go to the youtube channel

Click here to go to the website


iExposed Us 

P.O. Box 721

Scottsville Texas